Results 271 to 280 of about 197,639 (362)

Silencing of S100A11 attenuates murine metabolic dysfunction-associated steatohepatitis. [PDF]

NPJ Gut Liver
Daniel PV, Puri G, Luo Y, Golla N, Nishihara T, Erickson H, Marek G, Kengunte Nagaraj N, Povero D, Mauer AS, Liu J, Malhi H.   +11 more
europepmc   +1 more source

Female glucagon receptor knockout mice are prone to steatosis but resistant to weight gain when fed a MASH‐promoting GAN diet and a high‐fat diet

Katrine D. Galsgaard, Emilie Elmelund, Jenna Elizabeth Hunt, Mark M. Smits, Trisha J. Grevengoed, Christina Christoffersen, Nils J. Færgeman, Jesper F. Havelund, Nicolai J. Wewer Albrechtsen, Jens J. Holst   +9 more
openalex   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease After Hepatitis C Virus Cure

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Hepatitis C virus (HCV) infection is an infectious disease carrying a high risk of metabolic disorders. Chronic HCV (CHC) patients can possess extrahepatic manifestations such as diabetes, steatotic liver disease (SLD), and other metabolic alterations.
Chung‐Feng Huang, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang   +3 more
wiley   +1 more source

Studying the Effect of Hepatic Steatosis on Liver Stiffness Measurement (LSM) in HBV Patients With and Without Therapy. [PDF]

Int J Hepatol
Lak E, Jasemi Zergani F, Shokati Eshkiki Z, Hajiani E, Talebi V, Mohamadi S.   +5 more
europepmc   +1 more source

Towards Comprehensive Chronic Disease Control: Prevention, Early Detection, and Integrated Management

Medicine Bulletin, EarlyView.
ABSTRACT Chronic non‐communicable diseases (NCDs), including cardiovascular disease, diabetes, cancer, and chronic respiratory conditions, represent the leading causes of morbidity and mortality worldwide. This review examines comprehensive strategies across the continuum of care (from primary prevention and early screening to timely diagnosis ...
Ping Sun, Zhengwei Wan, Yuping Liu
wiley   +1 more source

Severity of Non-Alcoholic Fatty Liver Disease Assessed by FibroScan in Patients With and Without Ischemic Heart Disease: A Cross-Sectional Study. [PDF]

Cureus
Shaikh K, Karim S, Ahmed N, Basit A, Batool N, Kaleem F.   +5 more
europepmc   +1 more source

Copper-InducedDRP1 Activation Disrupts Mitochondrial-LipidDroplet Contact to Promote Hepatic Steatosis

Quanwei Li (2285224), Luna Su (19066481), Pan Guo (591765), Jianzhao Liao (11997708), Zhaoxin Tang (9471658)   +4 more
openalex   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Role of central and peripheral serotonin in liver physiology and diseases. [PDF]

Theranostics
Belmer A, Luci C, Gual P.
europepmc   +1 more source